Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 7,196

Document Document Title
WO/2015/014326A3
The present invention relates to a modified oligoester constituted by an oligoester (1) that, at one of the ends thereof has a group that reacts with organic acids or alcohols, forming covalent bonds, and at one or more of the other ends...  
WO/2015/016815A1
Antiperspirant and/or deodorant compositions containing lactic acid oligomers. The lactic acid oligomers provide a long lasting protection.  
WO/2015/012156A1
The present invention pertains to compounds having a 2,6-difluorophenyl ether structure useful as an organic electronic material, or a medical or agricultural chemical, and particularly as a material for liquid crystal display elements; ...  
WO/2015/009061A1
The present invention relates to a polyketone polymerization catalyst and, more specifically, to: a novel polyketone polymerization catalyst, which is prepared by using ((2,2-dimethyl-1,3-dioxane-5,5-diyl)bis(methylene))bis(bis(2 -methox...  
WO/2014/202168A1
Compounds of the formula I in which R1, R4, R6, R, X1, X2, X3, X4, q and W have the meanings indicated in Claim 1, are inhibitors of fatty acid synthase, and can be employed, inter alia, for the treatment of diseases such as cancer, card...  
WO/2014/203045A1
The present invention provides a process of preparation of an intermediate useful for the preparation of statins more particularly the present invention relates to an eco-friendly and cost effective process for the preparation of tert -b...  
WO/2014/200682A1
Both JNK and LRRK2 are associated with Parkinson's disease (PD), myocardial infarction (Ml), and other medical disorders. Here we report a reasonably selective and potent kinase inhibitors (e.g., compounds 6 and 10) that bound to both JN...  
WO/2014/192627A1
A liquid crystal medium that has stability to heat, light and the like, also has extremely high dielectric anisotropy, and can develop an optically isotropic liquid crystal phase has been demanded. Various optical elements each of which ...  
WO/2014/180556A1
The present invention relates to arylpiperazines, and to the efficient treatment of an individual afflicted with L-DOPA-induced dyskinesia, which condition typically arises as a consequence of long-term treatment with L-DOPA therapy in P...  
WO/2014/180836A1
The invention relates to a process for the recovery and production of meso-lactide from a crude lactide containing stream, which comprises the steps of: a. Subjecting a starting crude lactide stream to a first distillation step to obtain...  
WO/2014/177512A1
The invention relates to a method for storage and/or transport of solid lactide particles in a container, said method comprising the steps of a) inserting the lactide particles into the container, b) storing and/or transporting the lacti...  
WO/2014/173047A1
A technological method for synthesizing optical pure L-/D-lactide by using a biomass organic guanidine catalysis method. The method of the present invention comprises: by using biomass organic guanidine compound creatinine (CR) as a cata...  
WO/2014/176151A1
The present application relates to perfume delivery systems and consumer products comprising such perfume delivery systems, as well as processes for making and using such perfume delivery systems and consumer products. Such perfume deliv...  
WO/2014/171894A1
The present invention provides a method of synthesizing a cyclic carbonate comprising the step of reacting an alcohol with carbon dioxide.in the presence of a base.  
WO/2014/157140A1
A method for producing glycolide (GL) by heating a glycolic acid oligomer (GAO) to depolymerize the GAO. The method comprises: a step (1) of heating a mixture comprising GAO having a terminal COOH concentration of 400 eq/t or less and a ...  
WO/2014/156809A1
In the present invention, a method for producing a glycolide (GL) includes the following: (I) a heating step of heating a mixture either under atmospheric pressure or reduced pressure at a temperature whereby a poly(glycolic acid) (PGA) ...  
WO/2014/150782A1
A ketal amide has a structure represented by formula (I): wherein R is hydrogen or C1-8 alkyl; R1 is substituted or unsubstituted, saturated or unsaturated C1-36 alkyl, or an alkylene oxide of the formula (CnH2nO)pCnH2nORa wherein n is 1...  
WO/2014/140220A1
The present invention is directed to aprocess for the preparation of (2,3- dihydrobenzo[b][1,4]dioxin-2-yl)methanolderivatives.  
WO/2014/139730A1
The invention relates to a process for purification of a stream containing a cyclic ester of an alpha- hydroxycarboxylic acid of formula (I), wherein each R independently represents hydrogen or an aliphatic hydrocarbon having 1 to 6 carb...  
WO/2014/134005A3
Methods of preparing carbamate prodrugs of amine-containing drugs are provided. Carbonates useful in the synthesis of the carbamate prodrugs are also provided.  
WO/2014/129268A1
Provided are: a liquid crystal compound satisfying at least one property such as high stability to light, high clearing point, low minimum temperature of the liquid crystal phase, low viscosity, suitable optical anisotropy, large dielect...  
WO/2014/125911A1
Provided are: a liquid-crystalline compound which satisfies at least one property selected from high stability to light, a high clear point, a low lower-limit temperature of a liquid crystal phase, a low viscosity, proper optical anisotr...  
WO/2014/122294A1
The invention relates to a process for preparing a cyclic ester or a cyclic amide, comprising the step of: contacting at least one hydroxycarboxylic acid and/or at least one amino-carboxylic acid; or an ester, or salt thereof; wherein sa...  
WO/2014/111490A1
The present invention relates to a new biofuel formulation comprising: crude glycerol, glycerol formal, optionally at least one fatty acid glycerol formal ester and optionally at least one fatty acid methyl ester. The present invention a...  
WO/2014/097171A1
The present invention relates to a process of a cis/trans isomerization of an unsaturated compound A being selected from the group consisting of unsaturated ketones, unsaturated ketals, unsaturated aldehydes, unsaturated acetals, unsatur...  
WO/2014/096066A1
The present invention relates to a process of manufacturing (6R,10R)-6,10,14-trimetylpentadecan-2-one in a multistep synthesis from (R)-3,7-dimethyloct-6-enal. The process is very advantageous in that it forms in an efficient way the des...  
WO/2014/097952A1
Provided is a chiral compound having considerable helical twisting power, a low melting point, and good solubility with other liquid-crystal compounds. Also provided is a liquid-crystal compound composed of the chiral compound of the pre...  
WO/2014/096063A1
The present invention relates to a process of manufacturing (6R,10R)-6,10,14-trimetylpentadecan-2-one in a multistep synthesis from 3,7-dimetyloct-2-enal or 3,7-dimetylocta-2,6-dienal. The process is very advantageous in that it forms th...  
WO/2014/097172A1
The present invention relates to a process of a cis/trans isomerization of an unsaturated compound A being selected from the group consisting of unsaturated ketones, unsaturated ketals, unsaturated aldehydes, unsaturated acetals, unsatur...  
WO/2014/083936A1
The present invention addresses the problem of providing a method that produces a higher yield of a carbonyl compound. In this production method for a carbonyl compound, dealkoxycarbonylation of a compound represented by formula (II) is ...  
WO/2014/083186A3
There is provided a compound comprising the general structure (I) in which, X is N or O; R3 is OR4 or R4; wherein when X is N, R1 is H, R5 or OR6; R2 is OC(O)R7; and R4 is R5, OR5 or aryl, which is unsubstituted or substituted with at le...  
WO/2014/083935A1
The present invention addresses the problem of providing a method that produces a higher yield of a carbonyl compound. In this production method for a carbonyl compound, dealkoxycarbonylation of a compound represented by formula (II) is ...  
WO/2014/083186A2
There is provided a compound comprising the general structure (I) in which, X is N or O; R3 is OR4 or R4; wherein when X is N, R1 is H, R5 or OR6; R2 is OC(O)R7; and R4 is R5, OR5 or aryl, which is unsubstituted or substituted with at le...  
WO/2014/083911A1
A method for producing a cyclopentanone derivative represented by general formula (III), wherein a cyclopentanone derivative represented by general formula (III) can be produced with higher yield since the method comprises a step wherein...  
WO/2014/081558A1
Disclosed is a process for making diastereomeric N-sulfinyl α-amino amides by reaction of chiral sulfinimines with formamides and lithium diisopropylamide. The process of the invention provides the N-sulfinyl α-amino amides in high yie...  
WO/2014/080876A1
A method for producing GL, which is provided with: step (1) wherein a GAO composition, which preferably contains a high-boiling-point organic solvent or a solubilizing agent, is supplied into a reaction container and heated to a temperat...  
WO/2014/074365A1
The present invention provides compounds of Formula I. Wherein Rl, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridem...  
WO/2014/072453A1
The present invention relates to a process for obtaining simultaneously several compositions comprising fatty acid alkyl esters (biodiesel), glycerol formal and fatty acid glycerol formal esters.  
WO/2014/064160A1
The present invention relates to a process for preparing cyclic carboxylic esters, especially intramolecular lactones, for example dilactide, wherein these cyclic esters are prepared from oligomeric carboxylic acids by cyclizing depolyme...  
WO/2014/065293A1
A liquid-crystal composition exhibiting an optically isotropic liquid crystal phase, and containing a chiral agent and an achiral component (T) which contains one or more types of a compound (1) having: a dioxane ring which is unsubstitu...  
WO/2014/054391A1
A compound represented by general formula (1). In general formula (1), R1 represents either one of a protective group for a hydroxy group and a hydrogen atom, and R2 and R3 independently represent a protective group for an amino group.  
WO/2014/053694A1
Compounds of formula I, wherein A, B, X, Z and R1-R6, are as defined in the claims, exhibit TRPA 1 activity and are thus useful as TRPA1 modulators.  
WO/2014/046193A1
Provided are: an organocopper complex having a structure represented by general formula (1); a copper oxide thin film comprising the organocopper complex; a method for producing the copper oxide thin film; and a compound constituting the...  
WO/2014/041059A1
The invention provides a process for the production of a compound of formula (I), said process comprising reacting a compound of formula (II) with a compound of formula (III) wherein R1 and R2 may be the same or different and are selecte...  
WO/2014/041058A1
The invention provides a process for the production of 1 a compound of formula (I), said process comprising reacting a compound of formula (II), with a compound of formula (III), wherein R1 and R2 may be the same or different and are sel...  
WO/2014/036766A1
Provided is a smectic phase A liquid crystal material, comprising a heterocyclic compound; the heterocycle is a nitrogen-containing heterocycle formed by replacing 1-4 carbon atoms in a benzene ring with nitrogen atoms, or a heterocycle ...  
WO/2014/033046A1
The invention relates to a process for preparing compounds containing isocyanate groups and cyclic carbonate structures, by reacting at least A) a monomeric diisocyanate with aliphatically, cycloaliphatically, araliphatically and/or arom...  
WO/2014/030820A1
The present invention provides a method for directly preparing lactide through the dehydration reaction of lactic acid in the presence of a catalyst containing a tin compound, preferably a tetravalent compound. The method of the present ...  
WO/2014/028487A1
Provided herein are lipidoids that may be prepared from the conjugate addition of alkylamines to acrylates. In some embodiments, provided lipidoids are biodegradable and may be used in a variety of drug delivery systems. Given the amino ...  
WO/2014/011120A1
The present invention generally relates to processes and methods for the synthesis of endoperoxide compounds. More specifically, the invention relates to a method for preparing endoperoxide compounds starting from an aryl imine of formul...  

Matches 51 - 100 out of 7,196